Bicocca Open Archive

Logo unimib boa
SERAVALLE, GINO LUCIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.627
AS - Asia 4.200
EU - Europa 3.324
SA - Sud America 703
Continente sconosciuto - Info sul continente non disponibili 382
AF - Africa 123
OC - Oceania 13
Totale 18.372
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.944
SG - Singapore 1.557
CN - Cina 816
IT - Italia 816
HK - Hong Kong 600
RU - Federazione Russa 574
DE - Germania 564
VN - Vietnam 557
CA - Canada 545
BR - Brasile 497
IE - Irlanda 325
SE - Svezia 300
GB - Regno Unito 169
FR - Francia 159
IN - India 129
AT - Austria 105
BD - Bangladesh 105
UA - Ucraina 87
AR - Argentina 78
ID - Indonesia 70
KR - Corea 64
FI - Finlandia 49
IQ - Iraq 43
TR - Turchia 41
ZA - Sudafrica 41
PK - Pakistan 40
MX - Messico 38
EC - Ecuador 37
JP - Giappone 35
DK - Danimarca 31
CO - Colombia 29
PL - Polonia 26
SA - Arabia Saudita 24
ES - Italia 22
NL - Olanda 21
UZ - Uzbekistan 20
CR - Costa Rica 18
PH - Filippine 17
VE - Venezuela 16
BE - Belgio 14
EG - Egitto 13
MY - Malesia 13
TT - Trinidad e Tobago 13
CL - Cile 12
HN - Honduras 12
PY - Paraguay 12
TN - Tunisia 12
JM - Giamaica 11
PR - Porto Rico 11
PE - Perù 10
AU - Australia 9
GT - Guatemala 9
ET - Etiopia 8
KE - Kenya 8
NI - Nicaragua 8
TH - Thailandia 8
BG - Bulgaria 7
JO - Giordania 7
MA - Marocco 7
AE - Emirati Arabi Uniti 6
CW - ???statistics.table.value.countryCode.CW??? 6
IL - Israele 6
KG - Kirghizistan 6
LT - Lituania 6
SN - Senegal 6
AL - Albania 5
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
HU - Ungheria 5
MK - Macedonia 5
NG - Nigeria 5
BO - Bolivia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
EU - Europa 4
IR - Iran 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
RS - Serbia 4
SC - Seychelles 4
UY - Uruguay 4
EE - Estonia 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
SR - Suriname 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
BB - Barbados 2
BH - Bahrain 2
BJ - Benin 2
CI - Costa d'Avorio 2
GD - Grenada 2
GE - Georgia 2
HR - Croazia 2
KZ - Kazakistan 2
Totale 17.970
Salva come PNG Salva come JPEG
Città #
Ashburn 880
Ann Arbor 877
Singapore 859
Hong Kong 585
San Jose 566
Fairfield 495
Frankfurt am Main 414
Toronto 399
Chandler 317
Dublin 313
Council Bluffs 308
Milan 278
Wilmington 260
New York 248
Houston 225
Woodbridge 221
Seattle 220
Dallas 212
Ho Chi Minh City 165
Santa Clara 143
Dearborn 140
Beijing 137
Los Angeles 136
Chicago 135
Princeton 132
Cambridge 125
Hanoi 124
The Dalles 108
Vienna 96
Hefei 81
Jacksonville 76
Moscow 76
Lauterbourg 69
Rome 68
Altamura 58
Lawrence 56
Seoul 56
Atlanta 55
Buffalo 50
Nanjing 50
Boardman 47
Shanghai 46
São Paulo 44
Jakarta 42
San Diego 36
Dong Ket 33
Montreal 32
Munich 30
Brooklyn 29
London 29
North Bergen 29
Haiphong 28
Orem 28
Phoenix 26
Helsinki 25
San Francisco 25
Columbus 24
Da Nang 24
Denver 24
Lissone 24
Tokyo 24
Guangzhou 23
Baghdad 22
Turin 22
Salt Lake City 20
Andover 19
Warsaw 18
Figino 17
Nanchang 17
Tashkent 17
Kunming 15
Memphis 15
Jiaxing 14
Mumbai 14
Rio de Janeiro 14
Shenyang 14
Belo Horizonte 13
Bologna 13
San José 13
Tianjin 13
Brussels 12
Changsha 12
Charlotte 12
Chennai 12
Miami 12
Nuremberg 12
Poplar 12
Quito 12
Boston 11
Johannesburg 11
Lahore 11
Queens 11
Edmonton 10
Jeddah 10
Jinan 10
Manchester 10
Philadelphia 10
Brasília 9
Cairo 9
Hebei 9
Totale 10.992
Salva come PNG Salva come JPEG
Nome #
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 636
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 381
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 370
Heart rate as cardiovascular risk factor 358
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 350
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 322
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 317
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 306
Evaluation of relationship between cardio-ankle vascular index and 24h ambulatory blood pressure variables 303
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 303
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 300
Neuroadrenergic activation in obstructive sleep apnoea syndrome: A new selectedmeta-analysis - revisited 299
Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity 297
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 296
Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights 293
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY 283
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 280
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction 275
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 270
Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure 270
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 257
Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up 254
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 253
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report 247
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage 240
Neuroadrenergic activation in obstructive sleep apnea syndrome: a systematic review and meta-analysis 235
Sympathetic Nervous System, Sleep, and Hypertension 233
Obesity and Hypertension 230
Baroreflex activation therapy systems: current status and future prospects 230
WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE 229
Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome 227
The role of carotid baroreceptor stimulation 226
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease 226
Effects of Renal Denervation on Sympathetic Nervous System Activity 224
New-onset aortic dilatation in the population: a quarter-century follow-up 223
Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: A time-integrated analysis 222
Elevated heart rate as sympathetic biomarker in human obesity 216
ANTIHYPERTENSIVE DRUG TREATMENT IN WHITE-COAT HYPERTENSION: DATA FROM THE PLAQUE HYPERTENSION LIPID-LOWERING ITALIAN STUDY (PHYLLIS) 204
Sympathetic activation in cardiovascular disease: Evidence, clinical impact and therapeutic implications 204
Heart rate as a predictor of cardiovascular risk 203
Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease 203
Age- and sex-specific reference values for media/lumen ratio in small arteries and relationship with risk factors 202
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 198
Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure 197
Blood pressure measurement, white-coat and masked hypertension 196
Clinical relevance of the sympathetic–vascular interactions in health and disease 196
Sympatho-Vagal Imbalance in Hypertension 193
The role of brain in neurogenic prehypertension 192
Association between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers 192
Obesity and hypertension 192
Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome 192
Sleep Apnea and Hypertension 191
Lercanidipine in the management of hypertension: An update 186
Differential effects of renal denervation on skin and muscle sympathetic nerve traffic in resistant and uncontrolled hypertension 180
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 180
Assessment of heart rate as 'sympathetic biomarker': Strengths and pitfalls 177
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population 176
Device-Based Treatment in Hypertension and Heart Failure 176
Cardiopulmonary receptor and arterial baroreceptor reflexes after acute myocardial infarction 176
Targeting persistent normal left ventricular geometry in the general population: a 25-year follow-up study 176
Visit-to-visit blood pressure variability is related to sympathetic neural drive and baroreflex sensitivity in hypertensive patients 175
Cardiovascular physiology: regulation of blood pressure 172
EFFECTS OF CAROTID BARORECEPTOR STIMULATION ON REGIONAL SYMPATHETIC ACTIVITY IN CHRONIC HEART FAILURE 171
Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment 170
Neural Mechanisms 169
Cigarette smoking and the adrenergic nervous system 169
Treatment of resistant hypertension 167
Neurohormonal interactions 160
Iatrogenic Aspects of sports cardiology and lifestyle modifications, Chapter 25: Trained Athletes 158
Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea 158
Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses 156
The Complex Relationship Between Serum Uric Acid, Endothelial Function and Small Vessel Remodeling in Humans 154
Baroreceptor Stimulation 153
Sympathetic Activity in Hypertension and Heart Failure 150
Arterial alterations in hypertension 149
Trained Athletes 144
Sympathomodulation in congestive heart failure: From drugs to devices 144
Sympathetic Overactivation in Patients With Essential Hypertension and Hepatic Iron Overload 139
Transient effects of carotid baroreflex stimulation via the neck chamber device on central venous pressure 139
Microvascular Alterations in Obesity 136
Corrigendum to “Obesity and hypertension” [Pharmacological Research 122 (2017) 1–7](S1043661817304620)(10.1016/j.phrs.2017.05.013) 134
The sympathetic nervous system in hypertension 130
ASSOCIATION BETWEEN HEART RATE TRESHOLDS FOR CARDIOVASCULAR RISK DEFINED BY NEW ESC/ESH GUIDELINES AND NEUROADRENERGIC MARKERS 112
Totale 18.372
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.510
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022639 0 0 0 0 75 64 64 56 41 89 77 173
2022/20231.521 169 421 170 135 96 250 28 66 100 17 48 21
2023/20241.082 30 34 46 107 155 278 173 25 100 17 16 101
2024/20252.531 150 318 112 92 196 97 169 107 242 372 269 407
2025/20266.245 519 310 489 665 653 319 950 299 455 496 551 539
2026/20272.724 187 599 659 945 334 0 0 0 0 0 0 0
Totale 18.372